Cost-effectiveness of in vitro fertilization and controlled ovarian hyperstimulation before and after the COVID-19 outbreak

References

• De Geyter C, Wyns C, Calhaz-Jorge C, et al. 20 Years of the European IVF-monitoring consortium registry: what have we learned? A comparison with registries from two other regions. Hum Reprod. 2020;35(12):2832–2849.
   PubMed Web of Science ®Google Scholar
• Batiha O, Al-Deeb T, Al-Zoubi E, et al. Impact of COVID-19 and other viruses on reproductive health. Andrologia. 2020;52(9):e13791.
   PubMed Web of Science ®Google Scholar
• Stoev S, Getov I, Timeva T, et al. Study of clinical experience with different approaches to controlled ovarian hyperstimulation: a focus on safety and efficacy. Eur J Hosp Pharm. 2021;28(1):33–37.
   PubMedGoogle Scholar
• Benbassat B, Mitov K, Savova A, et al. Cost-effectiveness of different types of COH protocols for in vitro fertilization at national level. Biotechnol Biotechnol Equip. 2017;31(1):206–221.
   Web of Science ®Google Scholar
• Zegers-Hochschild F, Adamson GD, de Mouzon J, World Health Organization, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009;92(5):1520–1524.
   PubMed Web of Science ®Google Scholar
• Rhodes TL, McCoy TP, Lee Higdon H, 3 rd, et al. Factors affecting assisted reproductive technology (ART) pregnancy rates: a multivariate analysis. J Assist Reprod Genet. 2005;22(9-10):335–346.
   PubMed Web of Science ®Google Scholar
• Gallos ID, Eapen A, Price MJ, et al. Arri Coomarasamy. Controlled ovarian stimulation protocols for assisted reproduction: a network meta∼analysis. [cited 2021 Jan 01]. https://www.cochrane.org/CD012586/MENSTR_controlled-ovarian-stimulation-protocols-assisted-reproduction-network-meta-analysis.
   Google Scholar
• Dodson WC, Haney AF. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril. 1991;55(3):457–467.
   PubMed Web of Science ®Google Scholar
• Scott RT, Toner JP, Muasher SJ, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51(4):651–654.
   PubMed Web of Science ®Google Scholar
• Jones GS, Acosta AA, Garcia JE, et al. The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women. Fertil Steril. 1985;43(5):696–702.
   PubMed Web of Science ®Google Scholar
• Jones GS, Garcia JE, Rosenwaks Z. The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human. J Clin Endocrinol Metab. 1984;59(1):178–180.
   PubMed Web of Science ®Google Scholar
• Murat A, Bocca S, Mirkin S, et al. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of elizabeth carr. Fertil Steril. 2005;84(3):555–569.
   PubMed Web of Science ®Google Scholar
• Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and Meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560–579.
   PubMed Web of Science ®Google Scholar
• Human Fertilization & Embryology Authority. Coronavirus (COVID-19) guidance for patients. https://www.hfea.gov.uk/treatments/covid-19-and-fertility-treatment/coronavirus-covid-19-guidance-for-patients/ (Assessed on 20.04. 2021.
   Google Scholar
• National Council of Prices and Reimbursement. Registries. http://portal.ncpr.bg/registers/pages/register/list-medicament.xhtml.
   Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed.; UK: Oxford University Press, 2015.
   Google Scholar
• Petrova G, Benbassat B, Lakic D, et al. Cost-effectiveness of short COH protocols with GnRH antagonists using different types of gonadotropins for in vitro fertilization. Biotechnol Biotechnol Equip. 2016; 30(3):614–621.
   Web of Science ®Google Scholar
• Benbassat B, Doneva M, Petrova G. Pharmacotherapy cost of controlled ovarian hyperstimulation of in vitro fertilization—a real life study. PP. 2014;05(10):919–925.
   Google Scholar
• Ministry of Health. Rules for the organization of work and activities of the center for assisted reproduction. State Gazette (2009); last amended State Gazette 95, 2019.
   Google Scholar
• Mantovani LG, Belisari A, Szucs TD. Pharmaco-economic aspects of in-vitro fertilization in Italy. Hum Reprod. 1999; 14(4):953–958.
   PubMed Web of Science ®Google Scholar
• Sykes D, Out HJ, Palmer SJ, et al. The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments. Hum Reprod. 2001; 16(12):2557–2562.
   PubMed Web of Science ®Google Scholar
• Wolzt M, Gouya G, Sator M, et al. Comparison of pharmacokinetic and safety profiles between bemfola(®) and gonal-f(®) after subcutaneous application. Eur J Drug Metab Pharmacokinet. 2016; 41(3):259–265.
   PubMed Web of Science ®Google Scholar
• ESHRE Reproductive Endocrinology Guideline Group. Ovarian Stimulation For IVF/ICSI. Guideline of the European Society of Human Reproduction and Embryology. 2019. (Assessed on 20.04.2021)
   Google Scholar
• Silverberg K, Daya S, Auray JP, et al. Analysis of the cost effectiveness of recombinant versus urinary follicle stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States. Fertil Steril. 2002; 77(1):107–113. doi:
   PubMed Web of Science ®Google Scholar
• Anifandis G, Messini CI, Daponte A, et al. COVID-19 and fertility: a virtual reality. Reprod Biomed Online. 2020; 41(2):157–159.
   PubMed Web of Science ®Google Scholar
• Andrabi SW, Jaffar M, Arora PR. COVID-19: New adaptation for IVF laboratory protocols. JBRA Assist Reprod. 2020; 24(3):358–361.
   PubMed Web of Science ®Google Scholar
• Alviggi C, Esteves SC, Orvieto R, et al. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol. 2020;18(1):45.
   PubMed Web of Science ®Google Scholar
• Esposito V, Rania E, Lico D, et al. Influence of COVID-19 pandemic on the psychological status of infertile couples. Eur J Obstet Gynecol Reprod Biol. 2020; 253:148–153.
   PubMed Web of Science ®Google Scholar
• Ben-Kimhy R, Youngster M, Medina-Artom TR, et al. Fertility patients under COVID-19: attitudes, perceptions and psychological reactions. Hum Reprod. 2020; 35(12):2774–2783.
   PubMed Web of Science ®Google Scholar
• Smith ADAC, Gromski PS, Rashid KA, et al. Population implications of cessation of IVF during the COVID-19 pandemic. Reprod Biomed Online. 2020; 41(3):428–430.
   PubMed Web of Science ®Google Scholar